Abbott Laboratories (ABT) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.42% |
| Dec 31, 2025 | -15.11% |
| Sep 30, 2025 | 30.44% |
| Jun 30, 2025 | -23.02% |
| Mar 31, 2025 | -21.82% |
| Dec 31, 2024 | 20.56% |
| Sep 30, 2024 | -11.81% |
| Jun 30, 2024 | 44.67% |
| Mar 31, 2024 | 6.96% |
| Dec 31, 2023 | 15.40% |
| Sep 30, 2023 | -17.64% |
| Jun 30, 2023 | -13.62% |
| Mar 31, 2023 | 33.45% |
| Dec 31, 2022 | 16.50% |
| Sep 30, 2022 | -10.52% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | 26.66% |
| Dec 31, 2021 | -49.94% |
| Sep 30, 2021 | 58.83% |
| Jun 30, 2021 | 22.96% |
| Mar 31, 2021 | 24.25% |
| Dec 31, 2020 | 3.75% |
| Sep 30, 2020 | 17.04% |
| Jun 30, 2020 | 10.96% |
| Mar 31, 2020 | 11.32% |
| Dec 31, 2019 | -20.00% |
| Sep 30, 2019 | 57.04% |
| Jun 30, 2019 | -40.45% |
| Mar 31, 2019 | 10.16% |
| Dec 31, 2018 | -51.13% |
| Sep 30, 2018 | 29.09% |
| Jun 30, 2018 | -20.71% |
| Mar 31, 2018 | 2.63% |
| Dec 31, 2017 | -20.90% |
| Sep 30, 2017 | 10.50% |
| Jun 30, 2017 | -19.66% |
| Mar 31, 2017 | -31.88% |
| Dec 31, 2016 | 61.39% |
| Sep 30, 2016 | -15.55% |
| Jun 30, 2016 | -20.68% |
| Mar 31, 2016 | -5.92% |
| Dec 31, 2015 | 60.75% |
| Sep 30, 2015 | -8.97% |
| Jun 30, 2015 | -22.35% |
| Mar 31, 2015 | 35.33% |
| Dec 31, 2014 | -32.96% |
| Sep 30, 2014 | -30.66% |